V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270019155 | 270009904 | 1.8 | 81.7 | Adjuvant (A) | 2015-02-04 | 2015-03-05 | Cisplatin+Gemcitabine (Days 1&8&15) | N | N | 270017233 | AFLIBERCEPT + FU + IRINOTECAN |
| 270019156 | 270009919 | 1.71 | 58.7 | Palliative (P) | 2013-04-16 | 2013-11-06 | BENDAMUSTINE | N | N | 270017260 | BENDAMUSTINE |
| 270019157 | 270009925 | 1.61 | 62 | Adjuvant (A) | 2016-10-21 | 2016-12-02 | GEM-P | N | N | 270017261 | GEMCITABINE + PACLITAXEL |
| 270019158 | 270009934 | 1.61 | null | Curative (C) | 2014-10-24 | 2014-11-01 | Panitumumab | N | N | 270017276 | PANITUMUMAB |
| 270019159 | 270019946 | 1.72 | 98 | Palliative (P) | 2015-05-19 | 2015-05-19 | Oxaliplatin + Raltitrexed | N | N | 270017287 | GEMCITABINE |
| 270019160 | 270014645 | 1.79 | 89.4 | Curative (C) | 2016-04-28 | 2016-05-02 | Oxaliplatin + Raltitrexed | null | null | 270017290 | AFLIBERCEPT + FU + IRINOTECAN |
| 270019161 | 270009947 | 1.83 | 62.5 | Palliative (P) | 2016-08-27 | 2016-08-27 | IVE | 02 | N | 270017293 | IVE |
| 270019162 | 270009949 | 1.67 | 80.7 | Palliative (P) | 2017-09-11 | 2017-09-11 | Cisplatin | N | N | 270017301 | CETUXIMAB + OXALIPLATIN + MDG |
| 270019163 | 270009953 | 1.73 | 74 | Adjuvant (A) | 2017-09-02 | 2017-10-01 | Bevacizumab | N | N | 270017306 | CARBOPLATIN |
| 270019164 | 270014653 | null | 70 | Curative (C) | 2015-04-25 | 2015-05-11 | Irinotecan | N | N | 270017315 | IRINOTECAN |
| 270019165 | 270009964 | 1.85 | 101 | Curative (C) | 2014-09-23 | 2015-07-06 | Cisplatin | N | N | 270017328 | GEMCITABINE |
| 270019166 | 270009968 | 1.79 | null | Curative (C) | 2018-02-16 | 2018-02-16 | Cisplatin 7 day | 2 | null | 270017330 | OXALIPLATIN + RALTITREXED |
| 270019167 | 270009972 | 1.55 | 90.9 | Adjuvant (A) | null | 2015-12-23 | GEMCITABINE | 02 | N | 270017331 | CETUXIMAB + OXALIPLATIN + MDG |
| 270019168 | 270017091 | null | 102 | Curative (C) | 2016-12-24 | 2017-05-24 | GDP | N | N | 270017363 | GDP |
| 270019169 | 270017093 | 1.67 | 70.4 | Palliative (P) | 2018-10-04 | 2018-10-09 | Cyclophosphamide High Dose | N | N | 270017379 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270019170 | 270009991 | 1.83 | 77 | Adjuvant (A) | 2017-03-06 | 2017-04-03 | IGEV | null | null | 270017382 | CISPLATIN + GEMCITABINE |
| 270019171 | 270014669 | 1.81 | 61 | Adjuvant (A) | 2017-08-25 | 2017-08-25 | GEM-P | N | N | 270017404 | GEMCITABINE + PACLITAXEL |
| 270019172 | 270017097 | 1.55 | 95.6 | null | 2019-03-21 | 2019-03-21 | Cisplatin | 2 | N | 270017410 | CISPLATIN + GEMCITABINE |
| 270019173 | 270018477 | null | null | null | 2016-12-02 | 2016-12-10 | Cisplatin | N | N | 270017427 | IGEV |
| 270019174 | 270010013 | null | 57 | Adjuvant (A) | 2016-06-13 | 2016-09-26 | Bevacizumab 5mg/kg | N | N | 270017430 | CETUXIMAB + OXALIPLATIN + MDG |
| 270019175 | 270010015 | 1.9 | 99.7 | Curative (C) | 2015-11-20 | 2015-11-19 | Bendamustine +/- Prednisolone | 2 | N | 270017431 | BENDAMUSTINE |
| 270019177 | 270010022 | 1.74 | 50.5 | Curative (C) | 2013-12-30 | 2013-12-31 | Vinblastine | N | N | 270017436 | IGEV |
| 270019178 | 270010025 | 1.8 | 59.1 | Neo-adjuvant (N) | 2019-01-09 | 2019-01-09 | IGEV | 2 | N | 270017438 | OXALIPLATIN + RALTITREXED |
| 270019179 | 270010029 | null | 68.3 | Curative (C) | 2014-05-02 | 2014-06-05 | GEM-P | 2 | N | 270017455 | GEMCITABINE + PACLITAXEL |
| 270019180 | 270010031 | null | 127.3 | Palliative (P) | 2017-05-26 | 2017-05-29 | Bendamustine +/- Prednisolone | N | N | 270017456 | BENDAMUSTINE |
| 270019181 | 270010035 | 1.65 | 78.4 | Curative (C) | 2015-05-01 | 2015-05-07 | GEMCITABINE | N | Y | 270017460 | CARBOPLATIN |
| 270019182 | 270014687 | 0 | 65.6 | Curative (C) | 2015-05-21 | 2015-08-11 | GDP | N | null | 270017468 | GDP |
| 270019183 | 270010040 | 1.77 | 69.4 | Palliative (P) | 2017-05-27 | 2017-06-07 | Panitumumab | 02 | N | 270017469 | NIVOLUMAB |
| 270019185 | 270010049 | 1.8 | 66 | Curative (C) | null | 2016-09-05 | Bevacizumab 5mg/kg | null | null | 270017479 | VINBLASTINE |
| 270019186 | 270014694 | null | null | Palliative (P) | 2017-01-26 | 2017-07-13 | Panitumumab | N | N | 270017488 | NIVOLUMAB |
| 270019187 | 270010056 | 1.72 | 46.6 | Curative (C) | 2016-01-12 | 2016-01-18 | GEMCITABINE | N | Y | 270017496 | CARBOPLATIN |
| 270019188 | 270010059 | null | 79.4 | Curative (C) | 2017-11-06 | 2017-11-06 | BENDAMUSTINE | N | N | 270017498 | BENDAMUSTINE |
| 270019189 | 270010063 | 1.64 | 77.6 | Curative (C) | 2014-03-22 | 2014-03-22 | Carboplatin AUC 2 - 5 | N | N | 270017505 | ABVD R |
| 270019190 | 270010067 | 1.55 | 51.5 | Palliative (P) | 2018-12-02 | 2018-12-23 | VEPEMB | N | N | 270017507 | PANITUMUMAB |
| 270019191 | 270010075 | null | 74 | Palliative (P) | 2015-11-22 | 2016-04-05 | GDP | 02 | N | 270017577 | GDP |
| 270019192 | 270014706 | null | 50.5 | Curative (C) | null | 2014-05-03 | IVE | null | Y | 270017635 | IVE |
| 270019193 | 270019264 | 1.7 | null | Palliative (P) | 2014-07-06 | 2014-10-26 | Bevacizumab 7.5mg/kg | N | N | 270017661 | BEVACIZUMAB |
| 270019194 | 270010088 | 1.76 | 95.6 | Curative (C) | 2016-06-25 | 2017-03-14 | Panitumumab | 2 | Y | 270017686 | ABVD R |
| 270019195 | 270010095 | null | 66.9 | null | 2019-06-25 | 2019-08-27 | IVE | N | N | 270017787 | IVE |
| 270019196 | 270010097 | 1.57 | 58.8 | Palliative (P) | 2019-06-21 | 2019-06-21 | Carboplatin AUC 2 - 5 | N | N | 270017792 | AFLIBERCEPT + FU + IRINOTECAN |
| 270019197 | 270010100 | 1.81 | 74.4 | Curative (C) | 2017-06-22 | 2017-07-16 | CYCLOPHOSPHAMIDE + ETOPOSIDE | N | N | 270017821 | PEMBROLIZUMAB |
| 270019198 | 270010103 | 1.75 | 75 | Curative (C) | null | 2013-11-19 | FLUOROURACIL + RT | 2 | N | 270017822 | CHLORAMBUCIL + RITUXIMAB |
| 270019199 | 270010113 | 0 | 80.4 | Disease modification (D) | 2019-03-06 | 2019-03-13 | ICE (no GCSF) | N | N | 270017920 | PACE-BOM |
| 270019200 | 270010120 | null | 98 | Disease modification (D) | null | 2017-10-31 | Bortezomib + CYCLOPHOSPHAMIDE | null | null | 270018100 | CARBOPLATIN + CETUXIMAB + FU |
| 270019202 | 270014731 | null | 51.6 | Palliative (P) | 2016-01-22 | 2016-02-05 | CARBOPLATIN + RT | N | N | 270018142 | OXALIPLATIN + MDG + PANITUMUMAB |
| 270019203 | 270010125 | 1.83 | 74 | Curative (C) | 2014-12-02 | 2014-12-02 | DOXORUBICIN | 02 | N | 270018171 | MELPHALAN |
| 270019204 | 270014735 | null | null | Adjuvant (A) | 2014-09-20 | 2015-10-31 | CHLVPP PABLOE | N | N | 270018236 | CYCLOPHOSPHAMIDE |
| 270019205 | 270010138 | 1.8 | null | Curative (C) | 2017-09-13 | 2017-10-27 | Cyclophosphamide + Fludarabine IV | 02 | N | 270018255 | CVP R |
| 270019206 | 270010144 | 1.68 | 84.45 | Palliative (P) | 2018-03-30 | 2018-04-01 | Bevacizumab + CAPECITABINE + IRINOTECAN | 02 | N | 270018269 | BENDAMUSTINE + BRENTUXIMAB |
| 270019207 | 270010146 | 1.69 | 40 | Curative (C) | null | 2015-07-06 | CHLVPP PABLOE | N | Y | 270018302 | GDCVP |